Target intelligence / Profile preview

microRNA-720 (miR-720)

Target
miR-720
Molecular classification
Non-coding RNA, MicroRNA, tRNA-derived fragment (tRF), tRNA-derived small RNA (tsRNA)
01

Overview

microRNA-720 (miR-720) is a small non-coding RNA that was originally classified as a microRNA but was later identified as a fragment derived from tRNA-Thr (tRNA-derived fragment or tRF) (Arterioscler Thromb Vasc Biol, 2014). Despite its reclassification and removal from miRBase in 2012, it remains a significant subject of research due to its functional role in post-transcriptional gene regulation through RNA interference-like mechanisms, including Dicer-dependent biogenesis and association with Argonaute proteins (Arterioscler Thromb Vasc Biol, 2014; PNAS, 2011). miR-720 regulates a variety of critical targets, such as GATA3 in macrophage polarization (Biosci Rep, 2016), TWIST1 in breast cancer (Cell Biosci, 2015), and CCND1 in pancreatic cancer (Exp Ther Med, 2017). In clinical contexts, it acts as a context-dependent regulator, functioning as a tumor suppressor in breast and pancreatic cancers while exhibiting oncogenic properties in renal cell carcinoma and glioma (Mol Cancer Ther, 2017; J Liver Cancer, 2022). Its presence in serum and exosomes makes it a promising diagnostic and prognostic biomarker for several malignancies, including hepatocellular carcinoma and colorectal cancer (Korean J Intern Med, 2024; Tumour Biol, 2015). Therapeutic strategies currently focus on the use of miR-720 mimics or inhibitors to modulate its activity in disease states (Cell Biosci, 2015; Mol Cancer Ther, 2017).

Other names
miR-720hsa-miR-720tRNA-derived fragment 720tRF-720tRNA-Thr fragment
02

Mechanism of action

Regulation of target mRNA stability and translation through RNA interference-like mechanisms, specifically by binding to the 3' untranslated region (UTR) of target genes.

03

Biological functions

Post-transcriptional gene regulationCell proliferationCell migrationApoptosisAngiogenesisM2 macrophage polarizationStemness regulationInsulin secretion
04

Disease associations

CancerBreast cancerColorectal cancerPancreatic cancerCervical cancerRenal cell carcinomaGliomaHepatocellular carcinomaCoronary artery diseaseDiabetes mellitus type 2
05

Safety considerations

Off-target gene silencingTissue-specific pleiotropy (acting as oncogene or tumor suppressor)Delivery challenges for RNA-based therapeutics
06

Interacting drugs

miR-720 mimics

1 more in the full profile.

07

Biomarkers

Serum miR-720Exosomal miR-720Prognostic marker in colorectal cancerDiagnostic marker for hepatocellular carcinomaDiagnostic marker for renal cell carcinoma

Beyond the preview

Go deeper on microRNA-720 (miR-720).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA-720 (miR-720).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call